Jun-Jie Hao

Dr. Jun-Jie Hao

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JWJianxia Wen
Jianxia Wen
YYYi Yang
Yi Yang
JHJun-Jie Hao
Jun-Jie Hao
Acori Tatarinowii Rhizoma (ATR, Shi Chang Pu in Chinese), a natural product with multiple targets in various diseases. This review provides the comprehensive summary of the chemical composition, pharmacological effects, pharmacokinetics parameters and toxicity of ATR. The results indicated that ATR possesses a wide spectrum of chemical composition, including volatile oil, terpenoids, organic acids, flavonoids, amino acids, lignin, carbohydrates and so on. Accumulating evidence from various studies has shown that ATR exerts a wide range of pharmacological properties, including protecting nerve cells, alleviating learning and memory impairment, anti-ischemic, anti-myocardial ischemia, anti-arrhythmic, anti-tumor, anti-bacterial, and anti-oxidant activities. Currently, ATR is widely used in the central nervous system, cardiovascular system, gastrointestinal digestive system, respiratory system in China, and for the treatment of epilepsy, depression, amnesia, consciousness, anxiety, insomnia, aphasia, tinnitus, cancers, dementia, stroke, skin diseases, and other complex diseases. Pharmacokinetic studies indicated that β-asarone, α-asarone, cis-methylisoeugenol, and asarylaldehyde, the active components of ATR, were absorbed slowly after oral administration of ATR. Moreover, toxicity studies have suggested that ATR has no carcinogenic, teratogenic and mutagenic toxicity. Nevertheless, long term or high-dose toxicity testing in animals to explore the acute and chronic toxicity of acori Tatarinowii Rhizoma is still lacking. In view of good pharmacological activities, ATR is expected to be a potential drug candidate for the treatment of Alzheimer’s disease, depression, or ulcerative colitis. However, further studies are needed to elucidate its chemical composition, pharmacological effects, molecular mechanisms and targets, improve its oral bioavailability, and clarify its potential toxicity.

24 March 2025 in Phytomedicine
Verified
Journal Article
Closed access
JWJianxia Wen
Jianxia Wen
LLLu Li
Lu Li
DODinglin Ou
Dinglin Ou
JLJianling Li
Jianling Li
YYYi Yang
Yi Yang
YTYuling Tong
Yuling Tong

10 January 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
JWJianxia Wen
Jianxia Wen
MLMingjie Li
Mingjie Li
WZWenwen Zhang
Wenwen Zhang
HWHaoyu Wang
Haoyu Wang
YBYan Bai
Yan Bai
YZYanling Zhao
Yanling Zhao
Higenamine, a natural product with multiple targets in heart diseases, is originally derived from Aconitum, which has been traditionally used in China for the treatment of heart disease, including heart failure, arrhythmia, bradycardia, cardiac ischemia/reperfusion injury, cardiac fibrosis, etc. This study is aimed to clarify the role of higenamine in heart diseases. Higenamine has effects on improving energy metabolism of cardiomyocytes, anti-cardiac fibroblast activation, anti-oxidative stress and anti-apoptosis. Accumulating evidence from various studies has shown that higenamine exerts a wide range of cardiovascular pharmacological effects in vivo and in vitro, including alleviating heart failure, reducing cardiac ischemia/reperfusion injury, attenuating pathological cardiac fibrosis and dysfunction. In addition, several clinical studies have reported that higenamine could continuously increase the heart rate levels of healthy volunteers as well as patients with heart disease, but there are variable effects on systolic blood pressure and diastolic blood pressure. Moreover, the heart protection and therapeutic effects of higenamine on heart disease are related to regulating LKB1/AMPKα/Sirt1, mediating the β2-AR/PI3K/AKT cascade, induction of heme oxygenase-1, suppressing TGF-β1/Smad signaling, and targeting ASK1/MAPK (ERK, P38)/NF-kB signaling pathway. However, the interventional effects of higenamine on heart disease and its underlying mechanisms based on experimental studies have not yet been systematically reviewed. This paper reviewed the potential pharmacological mechanisms of higenamine on the prevention, treatment, and diagnosis of heart disease and clarified its clinical applications. The literature shows that higenamine may have a potent effect on complex heart diseases, and proves the profound medicinal value of higenamine in heart disease.

1 June 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XWXuan Wang
Xuan Wang
MNMing Niu
Ming Niu
SWShan-Na Wu
Shan-Na Wu
HHHuang-Wan-Yin Hu
Huang-Wan-Yin Hu
XLXiao-Yi Liu
Xiao-Yi Liu
LMLi Ma
Li Ma

1 March 2023 in Plant Disease
Verified
Journal Article
Closed access
JHJingyu Hu
Jingyu Hu
LZLei Zhang
Lei Zhang
ZYZhizhong Yang
Zhizhong Yang
HQHuali Qian
Huali Qian
ZXzhe xu
zhe xu
JDJiahong Dong
Jiahong Dong
Tulbaghia violacea Harv. indigenous to southern African countries, is an herbaceous perennial bulbous plant belonging to the family Amaryllidaceae. It is a popular garden plant in China. This attra...